Clinical trial

Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Cyclosporine…

NCT00154206 · Novartis Pharmaceuticals, Industry · Completed

Key facts

NCT number NCT00154206
Title Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Cyclosporine Microemulsion and Steroids in Pediatric de Novo Renal Transplant Patients
Official title A Multicenter, Open, Single Arm, Pilot Study to Evaluate Efficacy, Tolerability and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion and Steroids in Pediatric de Novo Renal Transplant Patients
Lead sponsor Novartis Pharmaceuticals, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Kidney Transplantation
Intervention type Drug
Interventions Enteric-Coated Mycophenolate Sodium (EC-MPS)
Enrollment 15
Start date Sep 1, 2004
Primary completion Jan 1, 2007
First posted Sep 12, 2005
Last update posted Feb 24, 2017
Countries Switzerland

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies